Theseus Pharmaceuticals, Inc.
News
Theseus Pharmaceuticals Announces Closing of Tender Offer
PR Newswire Theseus Pharmaceuticals Announces Closing of Tender Offer Theseus Pharmaceuticals Announces Closing of Tender Offer PR Newswire CAMBRIDGE, Mass., Feb. 14, 2024 -- Theseus Stockholders to Receive...\n more…
Theseus Pharmaceuticals: Biotech Buyout Remains Attractive At $4.06 Because Of 2-Part CVR
SeekingAlpha Theseus Pharmaceuticals: Biotech Buyout Remains Attractive At $4.06 Because Of 2-Part CVR...\n more…
Concentra Announces Calculation of Additional Price Per Share and Extension of Expiration Date for Tender Offer for Theseus Pharmaceuticals
Business Wire As previously announced on December 22, 2023, Concentra Biosciences, LLC (Parent) and its wholly owned subsidiary, Concentra Merger Sub II, Inc. (Purchaser), entered into a merger agreement (the...\n more…
Short Interest in Theseus Pharmaceuticals, Inc. (NASDAQ:THRX) Decreases By 42.2%
Ticker Report Theseus Pharmaceuticals, Inc. (NASDAQ:THRX Get Free Report) saw a large decrease in short interest during the month of December. As of December 15th, there was short interest totalling...\n more…
Needham Sticks to Its Hold Rating for Theseus Pharmaceuticals (THRX)
TipRanks Financial Blog In a report released today, Ami Fadia from Needham maintained a Hold rating on Theseus Pharmaceuticals (THRX - Research Report). The company's shar...\n more…